Controlling tumour recurrence | Anticancerfund
Controlling tumour recurrence icon

Controlling tumour recurrence

For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living with uncertainty is never easy. Discovering an intervention that can prevent cancer recurrence has the potential to significantly enhance quality of life.

Controlling tumour recurrence

Fighting the main threat: metastasis

Evidence is occasionally discovered supporting various, often simple interventions that improve existing treatment protocols. These additional therapies prevent tumour recurrence and contribute significantly to better outcomes. With 90% of deaths resulting from tumour recurrence and metastasis, primary tumours are not the main threat. While the mechanism of action of several interventions are not yet fully understood, research indicates that their influence on dormant cancer cells and the body’s own cancer-fighting mechanisms are at the core of their potential.

90%
of deaths
due to tumour recurrence

Our trials in this focus area

Trial phase: 
Phase 3
Cancer types: 
  • Melanoma
Status: 
Recruiting
Trial phase: 
Phase 3
Cancer types: 
  • Digestive cancers
Status: 
Recruiting
Trial phase: 
Phase 2
Cancer types: 
  • Breast cancer
Status: 
Recruiting

Our current focus areas

  • Drug repurposing

    Drug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse of existing...
  • Less common and rare cancers

    We don’t just focus on the ‘big four’ of cancer – prostate, colon, breast and lung. We also investigate new treatment...
  • Combination therapies

    It is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in combination can...
  • Controlling tumour recurrence

    For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living...

Ask for funding